Every lot published · search any lot number before you order

Retatrutide at 104 Weeks: Reading the Extension Data

Lilly reported an extension of TRIUMPH-1 for 532 participants who had a baseline BMI of at least 35 and completed and tolerated treatment in the main study. Follow-up extended to 104 weeks.

Retatrutide at 104 Weeks: Reading the Extension Data. An extension with selected participants. Study arm, Follow-up, Weight change. GLP LIFE SCIENCES ยท RESEARCH BRIEF 15 An extension with selected participants Weight loss studies Study armFollow-upWeight change
An extension with selected participants. Illustration for this research brief.

An extension with selected participants

Extension findings describe this selected group. The design also allowed changes to treatment, including moving the original placebo group to retatrutide, so the later estimates address a different question from the main placebo-controlled comparison.

How to interpret the evidence

Check who entered the extension and what happened to the original comparator before using its figures in a study summary.

When comparing results, record the primary outcome, the measurement week, and whether the analysis included outcomes after treatment stopped.

Sources